John Stephen Bridgeman

Person

Manchester, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Receptors providing targeted costimulation for adoptive cell therapy
- Patent number 12,187,778
- Issue date Jan 7, 2025
- INSTIL BIO (UK) LIMITED
- John Bridgeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cells expressing recombinant growth factor receptors
- Patent number 12,116,564
- Issue date Oct 15, 2024
- INSTIL BIO (UK) LIMITED
- John Stephen Bridgeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Receptors providing targeted costimulation for adoptive cell therapy
- Patent number 11,945,876
- Issue date Apr 2, 2024
- INSTIL BIO (UK) LIMITED
- John Bridgeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric molecules providing targeted costimulation for adoptive ce...
- Patent number 11,697,677
- Issue date Jul 11, 2023
- INSTIL BIO (UK) LIMITED
- John Bridgeman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cells expressing recombinant growth factor receptors
- Patent number 11,530,386
- Issue date Dec 20, 2022
- INSTIL BIO (UK) LIMITED
- John Stephen Bridgeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF FUSION CONSTRUCTS FOR IL-2 INDEPENDENT T CELL THERAPY
- Publication number 20240058447
- Publication date Feb 22, 2024
- Instil Bio (UK) Limited
- Owen R. Moon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CE...
- Publication number 20230331808
- Publication date Oct 19, 2023
- Instil Bio (UK) Limited
- John Bridgeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CE...
- Publication number 20230277670
- Publication date Sep 7, 2023
- Instil Bio (UK) Limited
- John Bridgeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
- Publication number 20230227576
- Publication date Jul 20, 2023
- Instil Bio (UK) Limited
- John Bridgeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLS EXPRESSING RECOMBINANT GROWTH FACTOR RECEPTORS
- Publication number 20230212511
- Publication date Jul 6, 2023
- Instil Bio (UK) Limited
- John Stephen Bridgeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CE...
- Publication number 20230059511
- Publication date Feb 23, 2023
- Instil Bio (UK) Limited
- John Bridgeman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
- Publication number 20230055694
- Publication date Feb 23, 2023
- Instil Bio (UK) Limited
- John Bridgeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
- Publication number 20230002470
- Publication date Jan 5, 2023
- INSTIL BIO (UK) LIMITED
- John Bridgeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
- Publication number 20230002504
- Publication date Jan 5, 2023
- Instil Bio (UK) Limited
- John Bridgeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOF
- Publication number 20220378826
- Publication date Dec 1, 2022
- Instil Bio (UK) Limited
- Nicola Kaye Price
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
- Publication number 20220348631
- Publication date Nov 3, 2022
- Instil Bio (UK) Limited
- John Bridgeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY
- Publication number 20220160760
- Publication date May 26, 2022
- Instil Bio (UK) Limited
- John Bridgeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chimeric Growth Factor Receptors
- Publication number 20210205365
- Publication date Jul 8, 2021
- Instil Bio (UK) Ltd.
- Nicola Kaye Price
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKER PREDICTIVE OF TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND...
- Publication number 20210000872
- Publication date Jan 7, 2021
- Instil Bio (UK) Ltd.
- Nicola Kaye Price
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

John Stephen Bridgeman

Person

Patents Grantslast 30 patents

Receptors providing targeted costimulation for adoptive cell therapy

Cells expressing recombinant growth factor receptors

Receptors providing targeted costimulation for adoptive cell therapy

Chimeric molecules providing targeted costimulation for adoptive ce...

Cells expressing recombinant growth factor receptors

Patents Applicationslast 30 patents

USE OF FUSION CONSTRUCTS FOR IL-2 INDEPENDENT T CELL THERAPY

CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CE...

CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CE...

RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY

CELLS EXPRESSING RECOMBINANT GROWTH FACTOR RECEPTORS

CHIMERIC MOLECULES PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CE...

RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY

RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY

RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY

TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND USES THEREOF

RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY

RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY

Chimeric Growth Factor Receptors

BIOMARKER PREDICTIVE OF TUMOUR INFILTRATING LYMPHOCYTE THERAPY AND...